Annual report pursuant to Section 13 and 15(d)

Document And Entity Information

v3.24.3
Document And Entity Information - USD ($)
 12 Months Ended
Jun. 30, 2024
Sep. 19, 2024
Dec. 31, 2023
Document And Entity Information      
Document Type 10-K/A    
Document Annual Report true    
Document Period End Date Jun. 30, 2024    
Document Transition Report false    
Securities Act File Number 001-35023    
Entity Registrant Name iBio, Inc.    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 26-2797813    
Entity Address, Address Line One 11750 Sorrento Valley Road    
Entity Address, Address Line Two Suite 200    
Entity Address, City or Town San Diego    
Entity Address, State or Province CA    
Entity Address, Postal Zip Code 92121    
City Area Code 302    
Local Phone Number 355-0650    
Title of 12(b) Security Common Stock    
Trading Symbol IBIO    
Security Exchange Name NYSEAMER    
Entity Voluntary Filers No    
Entity Well-known Seasoned Issuer No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
Document Financial Statement Error Correction [Flag] false    
Entity Shell Company false    
Entity Common Stock, Shares Outstanding   8,637,895  
Entity Central Index Key 0001420720    
Current Fiscal Year End Date --06-30    
Document Fiscal Year Focus 2024    
Document Fiscal Period Focus FY    
Amendment Flag false    
Entity Public Float     $ 4,431,006
Auditor Name GRASSI & Co., CPAs, P.C.    
Auditor Firm ID 606    
Auditor Location Jericho, New York    
Amendment Description iBio, Inc. (the “Company”) is filing this Amendment No. 1 on Form 10-K/A (this “Amendment”) to amend its Annual Report on Form 10-K for the year ended June 30, 2024, filed with the Securities and Exchange Commission (the “SEC”) on September 20, 2024 (the “Original 10-K”).